This is not the outcome we want
As we thoroughly collate and evaluate three years of studying GLP-1 obesity drug trends among real-world populations, new patterns are emerging that help us understand how these drugs are being used and how external factors may be impacting persistence and health outcomes, said Pat Gleason, PharmD, assistant vice president, health outcomes, at Prime
- Pycnogenol Improves Endothelial Function in Coronary Artery Disease PubMed: Nishioka et al
The MMRM includes treatment group, gender, country, visit and visit-by-treatment as fixed effects and baseline value as covariate
Unlike nausea which peaks around weeks 6-8 and typically resolves, constipation can persist throughout treatment because it results from Retatrutides mechanism of slowing gut motility
Chem Commun 1:146147